Charts Gilead Sciences, Inc.

Stocks

Real-time Estimate Cboe BZX 21:52:35 24/08/2026 +04			5-day change	1st Jan Change
146.62 ^USD	+0.34%		+5.46%	+19.37%

03:35pm	Gilead Sciences, Inc. Receives European Commission Approval for Trodelvy Plus Pembrolizumab in First-Line Metastatic Triple-Negative Breast Cancer	CI
03:09pm	Gilead Sciences' Trodelvy Gains EU Approval for Breast Cancer	MT

Stock exchange

Nasdaq GILD 146.54 $ +0.29% 275M $

Markets		Price	Change	Volumes
Nasdaq	GILD	146.54USD	+0.29%	275M $
CBOE	GILD	146.68USD	+0.42%	8.14M $
Tradegate	GIS	125.72EUR	+0.48%	190K €
Boerse Muenchen	GIS	125.62EUR	+0.26%	106K €
Xetra	GIS	124.88EUR	-1.05%	87.17K €
Deutsche Boerse AG	GIS	125.56EUR	-0.44%	57K €
Mexican S.E.	GILD *	2,459.87MXN	+3.00%	738K $
Wiener Boerse	GILD	126.10EUR	+0.86%	23.58K €
CBOE	0QYQ	124.98EUR	-0.90%	12.5K €
Börse Stuttgart	GIS	125.54EUR	+0.14%	10.17K €
Lima	GILDUS	147.11USD	+5.90%	6.47K $
CBOE		124.70EUR	-0.89%	1.25K €
London S.E.	0QYQ	146.50USD	0.00%	293 $
Borsa Italiana	1GILD	119.00EUR	+0.22%	0 €
Swiss Exchange	GILD	146.26USD	+0.05%	0 $
Santiago S.E.	GILD	138.92USD	0.00%	0 $
Santiago S.E.	GILDCL	127,000.00CLP	0.00%	0 $
Swiss Exchange	GILD	117.14CHF	+0.14%	0 CHF
Sao Paulo	GILD34	62.64BRL	-0.02%	7.52K R$
Buenos Aires S.E.	GILD	58,150.00ARS	+2.15%	52.16M $
Buenos Aires S.E.	GILDD	37.95USD	+0.50%	303.6 $
Toronto S.E.	GILD	29.41CAD	-0.51%	31.23K $
Deutsche Boerse AG	GIS0	18.20EUR	+2.25%	0 €

ProRealTime Chart